Metraipolis › archive › dc_69ff06624e71

A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse… — Europe PMC PMID:41428769

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41428769
DOI
10.1042/bcj20253411
License (as archived)
solo-consultazione
Archived
2026-11-07T05:14:07.321Z
SHA-256 of the archived text
0ad468cec1a5b2c0fe6e25f771d1ca5e07f6aff1834a96162bd918e65115cae8
Stable URL of this page
https://metraipolis.com/documento/dc_69ff06624e71

How to cite

A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse… — Europe PMC PMID:41428769 — Europe PMC (en), https://europepmc.org/article/MED/41428769 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69ff06624e71 (Metraipolis archive dc_69ff06624e71, sha256 0ad468cec1a5b2c0fe6e25f771d1ca5e07f6aff1834a96162bd918e65115cae8)
BibTeX
@misc{dc69ff06624e71,
  title = {A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse… — Europe PMC PMID:41428769},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41428769},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69ff06624e71; sha256 0ad468cec1a5b2c0fe6e25f771d1ca5e07f6aff1834a96162bd918e65115cae8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41428769. Agents can read the archived copy with the MCP tool read_document.